Related Experiment Video
Updated: Jul 15, 2025
09:23
Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation
Published on: August 18, 2016
10.5K
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023
Essa Al-Mansor1, Meghan Mahoney2, Maxime Chenard-Poirier3
1The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
Current Oncology (Toronto, Ont.)
|September 27, 2023
Summary
The Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023 developed new treatment guidelines for gastrointestinal malignancies. These consensus statements offer updated recommendations for Canadian oncologists caring for patients with these cancers.
Area of Science:
- Gastroenterology
- Oncology
- Medical Education
Background:
- The Eastern Canadian Gastrointestinal Cancer Consensus Conference convened in Quebec City, February 2-4, 2023.
- The conference focused on establishing consensus on novel and evolving treatment strategies for gastrointestinal cancers.
- Participants comprised leading Canadian medical oncologists, radiation oncologists, pathologists, and surgical oncologists.
Framework:
- Consensus statements were formulated based on a rapid review of current literature.
- Discussions involved presenting and critically evaluating available evidence on treatment paradigms.
- The process aimed to synthesize expert opinions into actionable recommendations.
Implementation:
- The conference brought together multidisciplinary oncology specialists from Ontario, Quebec, and the Atlantic provinces.
- Key emerging and evolving treatment paradigms in gastrointestinal oncology were discussed.
- A structured approach involving literature review and expert deliberation was employed.
Implications:
- The resulting consensus statements provide updated guidance for managing gastrointestinal malignancies.
- These recommendations reflect the collective expertise of Canadian physicians specializing in gastrointestinal cancer care.
- The conference outcomes are expected to influence clinical practice and patient treatment across Eastern Canada.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
108
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
108
01:21Inflammatory Bowel Disease V: Surgical Management
164
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
164
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
102
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
102
01:20Gastrointestinal Motility Disorders
422
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
422
01:23Gastritis III: Clinical Manifestations and Management
314
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
314